Deal Type

GHO Capital Partners (GHO), a specialist investor in global healthcare, has agreed to acquire Scientist.com, a US-based AI-powered R&D orchestration platform that enables pharmaceutical...

Germany-based prosthetics company Ottobock is preparing to raise about €100m in new proceeds from a proposed €750m (US$885) IPO on the Frankfurt Stock Exchange....

Germany-based GBA Group, an international life science services company with over 3,500 employees in 13 countries, has acquired a majority stake in the Italy-based...

Czechia-based Zentiva, a European generics pharmaceutical company, has changed hands between Advent and GTCR – two global PE firms. The sale - for a...

Nasdaq-listed GE HealthCare is to acquire icometrix, a Belgium-based company focused on providing AI-powered brain imaging analysis for neurological disorders. The acquisition addresses the...

TVM Capital Healthcare, a global private equity investor and operator specialised in healthcare growth capital across emerging markets, has announced the first close of...

Symeres, a Netherlands-headquartered mid-sized transatlantic CRDMO, has acquired DGr Pharma, a Netherlands-based drug development-focused consultancy, to expand its integrated early-stage drug development services and...

Switzerland-based multinational pharmaceutical company Novartis is acquiring Nasdaq-listed Tourmaline Bio, a US-based clinical-stage biopharmaceutical company focused on developing pacibekitug, an anti-IL-6 mAb, as a treatment...

Belgium-based A.forall, a pharmaceutical group that distributes EU-sourced pharmaceuticals to wholesalers and hospitals, has acquired Provepharm’s US generics portfolio. Provepharm is a France-based independent,...

Global private equity healthcare specialist Archimed has expanded Consumer Health presence with the acquisition of Groupe Laboratoire Rivadis, a France-based developer of baby and...